Get the Stockscreener App
50.02
2.19%
1.0913
Inari Medical Inc stock is traded at $50.02, with a volume of 164.76K.
It is up +2.19% in the last 24 hours and up +19.28% over the past month.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
See More
Previous Close:
$48.93
Open:
$48.75
24h Volume:
164.76K
Relative Volume:
0.19
Market Cap:
$2.90B
Revenue:
$547.47M
Net Income/Loss:
$-57.05M
P/E Ratio:
-833.69
EPS:
-0.06
Net Cash Flow:
$16.91M
1W Performance:
+1.67%
1M Performance:
+19.28%
6M Performance:
+18.96%
1Y Performance:
+3.52%
1-Day Range:
$48.44
$50.08
1-Week Range:
$46.80
$50.29
52-Week Range:
$36.73
$67.13
Inari Medical Inc Stock (NARI) Company Profile
Name
Inari Medical Inc
Sector
Industry
Phone
949-923-4747
Address
6001 OAK CANYON, SUITE 100, IRVINE, CA
Inari Medical Inc Stock (NARI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-24 | Initiated | Needham | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-29-22 | Initiated | Berenberg | Buy |
| Sep-13-22 | Initiated | Truist | Hold |
| Jun-21-22 | Initiated | Piper Sandler | Overweight |
| Mar-23-22 | Resumed | BofA Securities | Buy |
| Dec-15-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-18-20 | Initiated | BTIG Research | Buy |
| Oct-29-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-28-20 | Initiated | SVB Leerink | Outperform |
| Jun-19-20 | Initiated | Canaccord Genuity | Buy |
| Jun-16-20 | Initiated | BofA/Merrill | Neutral |
| Jun-16-20 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-16-20 | Initiated | Wells Fargo | Equal Weight |
View All
Inari Medical Inc Stock (NARI) Latest News
William Blair Boosts Earnings Estimates for Inari Medical - MarketBeat
(NARI) Proactive Strategies - Stock Traders Daily
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday - MSN
Inari medical director William Hoffman sells $2 million in stock By Investing.com - Investing.com Canada
Inari Medical CEO Andrew Hykes sells $150,000 in stock - Investing.com India
Inari Medical CEO Andrew Hykes sells $150,000 in stock By Investing.com - Investing.com Canada
Director William Hoffman Sells 40,000 Shares of Inari Medical In - GuruFocus.com
Inari medical director William Hoffman sells $2 million in stock - Investing.com
Inari Medical shares hold as Canaccord affirms Buy rating By Investing.com - Investing.com Australia
Leerink Partnrs Expects Increased Earnings for Inari Medical - MarketBeat
Inari Medical shares hold as Canaccord affirms Buy rating - Investing.com
Piper Sandler raises Inari Medical stock target on strong Q3 revenue - Investing.com Australia
Inari Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
FY2026 EPS Estimates for Inari Medical Decreased by Analyst - MarketBeat
Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y - MSN
BTIG keeps Buy rating on Inari shares, upbeat following beat-and-raise Q3 - Investing.com Canada
Inari Medical Inc (NARI) Q3 2024 Earnings: Revenue Hits $153M, E - GuruFocus.com
Inari Medical Q3 2024 Earnings Preview - MSN
Inari Medical stock target boosted on profit beat, Hold rating upheld By Investing.com - Investing.com South Africa
BTIG keeps Buy rating on Inari shares, upbeat following beat-and-raise Q3 By Investing.com - Investing.com South Africa
Inari Medical stock price target raised on strong growth outlook By Investing.com - Investing.com South Africa
Piper Sandler raises Inari Medical stock target on strong Q3 revenue By Investing.com - Investing.com South Africa
Inari Medical, Hertz Global, Fastly, and Ryvyl Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire
Inari Medical, Hertz Global, Fastly, and Ryvyl Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire Inc.
Earnings call: Inari Medical posts record revenue in Q3, aims for profitability By Investing.com - Investing.com South Africa
Earnings call: Inari Medical posts record revenue in Q3, aims for profitability - Investing.com Australia
Inari Medical Breaks Above 200-Day Moving AverageBullish for NARI - Nasdaq
Inari Medical Inc (NARI) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance ... - Yahoo Finance
Inari Medical Inc (NARI) Q3 2024 Earnings Call Highlights: Recor - GuruFocus.com
PEERLESS Results Show Superiority of FlowTriever® Compared - GlobeNewswire
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism - StockTitan
Inari Medical (NASDAQ:NARI) Shares Gap Up After Analyst Upgrade - MarketBeat
Inari Medical, Inc. (NASDAQ:NARI) Q3 2024 Earnings Call Transcript - MSN
Inari Medical stock target boosted on profit beat, Hold rating upheld - Investing.com
Key Takeaways From Inari Medical Analyst Ratings - Benzinga
Inari Medical stock price target raised on strong growth outlook - Investing.com India
Inari Medical (NASDAQ:NARI) Receives Hold Rating from Needham & Company LLC - MarketBeat
Inari Medical (NASDAQ:NARI) Price Target Increased to $52.00 by Analysts at Piper Sandler - MarketBeat
Inari Medical revenue jumps 21% to USD 153 in Q3 2024 - Medical Buyer
Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates - MSN
Inari Medical Reports Third Quarter 2024 Financial Results - GlobeNewswire
Can Inari's Strong Q2 Results, Rosy Outlook Revitalize Its Shares? - RTTNews
Inari Medical: A $4 Billion Opportunity Is Wide Open - Seeking Alpha
Inari Medical's Earnings: A Preview - Benzinga
Inari Medical, Inc. (NASDAQ:NARI) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Analysts Estimate Inari Medical, Inc. (NARI) to Report a Decline in Earnings: What to Look Out for - MSN
How the (NARI) price action is used to our Advantage - Stock Traders Daily
Okami Medical Announces Closing Of $32.5M Financing - Marketscreener.com
Inari Medical (NARI) to Release Quarterly Earnings on Monday - MarketBeat
Inari Medical 2-Year Revenue Jumps 63% to $547.5M - Orange County Business Journal
Inari Medical director William Hoffman sells $1.8 million in stock By Investing.com - Investing.com Australia
Inari Medical Inc Stock (NARI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):